DI-METREX Drug Patent Profile
✉ Email this page to a colleague
When do Di-metrex patents expire, and what generic alternatives are available?
Di-metrex is a drug marketed by Pvt Form and is included in one NDA.
The generic ingredient in DI-METREX is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Di-metrex
A generic version of DI-METREX was approved as phendimetrazine tartrate by VIRTUS on December 31st, 1969.
Summary for DI-METREX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 21 |
Patent Applications: | 1,902 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DI-METREX at DailyMed |
US Patents and Regulatory Information for DI-METREX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pvt Form | DI-METREX | phendimetrazine tartrate | TABLET;ORAL | 085698-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |